Immatics NV IMTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 08/12/22 EDT
11.71UNCH (UNCH)
Volume
642
Close
11.71quote price arrow up+0.28 (+2.45%)
Volume
414,125
52 week range
5.75 - 16.30
Loading...
  • Open11.58
  • Day High11.74
  • Day Low11.38
  • Prev Close11.43
  • 52 Week High16.30
  • 52 Week High Date09/10/21
  • 52 Week Low5.75
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap736.91M
  • Shares Out62.93M
  • 10 Day Average Volume0.26M
  • Dividend-
  • Dividend Yield-
  • Beta0.40
  • YTD % Change-12.87

KEY STATS

  • Open11.58
  • Day High11.74
  • Day Low11.38
  • Prev Close11.43
  • 52 Week High16.30
  • 52 Week High Date09/10/21
  • 52 Week Low5.75
  • 52 Week Low Date05/12/22
  • Market Cap736.91M
  • Shares Out62.93M
  • 10 Day Average Volume0.26M
  • Dividend-
  • Dividend Yield-
  • Beta0.40
  • YTD % Change-12.87

RATIOS/PROFITABILITY

  • EPS (TTM)0.30
  • P/E (TTM)38.71
  • Fwd P/E (NTM)-11.92
  • EBITDA (TTM)12.213M
  • ROE (TTM)14.44%
  • Revenue (TTM)134.40M
  • Gross Margin (TTM)-
  • Net Margin (TTM)11.62%
  • Debt To Equity (MRQ)7.98%

EVENTS

  • Earnings Date11/14/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Immatics NV

There is no recent news for this security.

Profile

MORE
Immatics NV is a clinical-stage biopharmaceutical company that is based in the Netherlands. The Company is focused on the discovery and development of T-Cell eceptors with the goal of enabling a robust and specific T-Cell response against these targets. The Company develops targeted immunotherapies with an emphasis on treating solid tumors through two distinct therapeutic modalities: Adoptive Cell Therapies (ACT) and antibody-like TCR Bispecifics (TCER). Its wholly owned...
Address
Paul Ehrlich-Strasse 15
Tuebingen
72076
Germany

Top Peers

SYMBOLLASTCHG%CHG
NSTG
NanoString Technologies Inc
16.98-0.36-2.08%
SGMO
Sangamo Therapeutics Inc
6.33+0.51+8.76%
MOR
MorphoSys AG
5.90+0.07+1.20%
NKTR
Nektar Therapeutics
5.14+0.19+3.84%
EOLS
Evolus Inc
9.60+0.26+2.78%